(Q36149372)

12 August 2017

title

Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial (English)

1 reference

Hormone Replacement Therapy

12 August 2017

main subject

1 reference

2

Wilbert S Aronow

1 reference

12 August 2017

Jose Ness

1

1 reference

12 August 2017

Erin Newkirk

series ordinal

3

1 reference

12 August 2017

Deanna McDanel

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

The Journals of Gerontology

12 August 2017

published in

1 reference

12 August 2017

volume

60

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

460-462

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Health status of hormone replacement therapy users and non-users as determined by the SF-36 quality-of-life dimension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

Prescriptions for Estrogen Replacement Therapy in Ontario Before and After Publication of the Women's Health Initiative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

The impact of hormone replacement therapy on quality of life and willingness to pay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.4.460

21 January 2018

Identifiers

DOI

10.1093/GERONA/60.4.460

1 reference

12 August 2017

1 reference